Zoetis Inc (ZTS) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Zoetis Inc   (NYSE: ZTS)

Select the Financial Report: Select the Period:


Description of Zoetis Inc's Business Segments


Zoetis Inc. is a prominent leader in the animal health industry, striving to improve the health of animals and the well-being of pet owners, farmers, and veterinarians. The company offers a comprehensive array of segments, products, and services that cater to the specific needs of various species, ranging from livestock to companion animals. Here is an extensive exploration of Zoetis offerings across its diverse segments:

1. Livestock

The livestock segment focuses on enhancing the health and productivity of animals raised for food production or agricultural purposes. Key offerings in this domain include:

- Vaccines: Zoetis provides a robust lineup of vaccines aimed at preventing a variety of infectious diseases, crucial for safeguarding herds and flocks. These vaccines are tailored for species such as cattle, pigs, poultry, and sheep.

- Antibiotics: The antibiotics developed by Zoetis are essential for treating bacterial infections, managing disease outbreaks, and facilitating recovery in livestock. These products are used judiciously to promote animal health while minimizing resistance.

- Parasiticides: These products are designed to combat both internal and external parasites, ensuring livestock remain healthy and comfortable. Effective parasite control is critical for optimal growth and production.

- Nutritional Supplements: Zoetis offers fortified products that enrich the diet of livestock with essential vitamins and minerals, supporting overall health, growth, and productivity. These supplements are crucial for enhancing feed efficiency.

- Diagnostic Services: The companys diagnostic tools allow for early disease detection, enabling prompt interventions. By identifying health issues early, farmers can implement effective treatment strategies and minimize economic loss.

- Reproductive Technology: Solutions such as artificial insemination and embryo transfer are provided to improve breeding efficiency and genetic quality in livestock, ultimately enhancing productivity and profitability.

- Herd Management Software: This technology provides farmers with robust tools to monitor animal health, optimize nutritional programs, and implement better breeding strategies, improving overall herd management.

Companion Animals

In the companion animal segment, Zoetis focuses on the health and well-being of pet animals like dogs, cats, and horses through various products and services:

- Vaccination: Zoetis offers a broad spectrum of vaccines that protect companion animals from common infectious diseases, thereby prolonging their quality of life.

- Flea and Tick Control: The company provides a range of topical and oral treatments designed to prevent infestations of fleas and ticks, which can lead to serious health repercussions for pets.

- Heartworm Prevention: Medications offered by Zoetis help prevent heartworm disease, a significant threat to pet health, particularly in certain geographical regions.

- Pain Management: The companys products focus on alleviating pain due to various conditions, such as arthritis, enabling pets to maintain a good quality of life.

- Diagnostic Tests: Zoetis provides tests for infectious and genetic diseases, allowing veterinarians to develop targeted treatment and management plans tailored to individual pets.

- Allergy Testing: Proactive allergy testing services help identify specific allergens affecting pets, leading to better management and treatment options.

- Genetic Testing: Genetic testing services provide insights into predispositions to various hereditary diseases, assisting in preventive care and informed breeding.

Diagnostics

Zoetis is at the forefront of offering advanced diagnostic products and services essential for effective animal health management:

- Infectious Disease Testing Kits: Available for veterinarians, these kits enable rapid and accurate diagnosis of prevalent infectious diseases across different animal species.

- Genetic Disorder Testing: Tests designed to identify genetic conditions that may impact animal health, supporting better treatment and breeding decisions.

- Metabolic Disorder Testing: Tools that help detect nutritional imbalances or metabolic problems that could lead to diminished performance in animals.

- Laboratory Services: Zoetis provides a wide array of laboratory services, including histopathology (microscopic examination of tissues), microbiology (identification of bacteria), and toxicology (detecting poisons and toxins).

Genetic Testing

Genetic testing services by Zoetis serve both livestock and companion animals and offer valuable insights for breeding and health management:

- Breeding Decisions: Breeders can analyze traits such as disease susceptibility, coat color, and performance characteristics through genetic tests, facilitating informed and strategic decisions.

- Health Management: Genetic insights allow for early identification of potential health issues, enabling tailored management plans aimed at promoting animal welfare and productivity.

Pharmaceutical Products

Zoetis offers a diverse portfolio of pharmaceutical products designed to address various health conditions in animals:

- Antibiotics: Targeted antibiotics to manage infections effectively and facilitate recovery.

- Anti-inflammatories: Medications that alleviate inflammation and associated pain, enhancing the comfort of treated animals.

- Anesthetics: Vital for ensuring animal safety and comfort during surgical and other medical procedures.

- Sedatives: Used in clinical settings to calm animals during examinations or treatments.

Vaccines

Vaccination is a cornerstone of Zoetis’ offerings, with vaccines developed for a wide range of animal species, including:

- Cattle: Vaccines targeting specific viral and bacterial diseases that are critical for maintaining herd health.

- Pigs and Poultry: Vaccines developed for common infections, essential for the productivity of meat and poultry industries.

- Pets: Vaccines designed to protect household pets from prevalent viruses and bacteria, ensuring their longevity and wellness.

Nutritional Supplements

Zoetis also caters to the nutritional needs of both livestock and companion animals with supplements designed to improve health and performance:

- Essential Nutrients: These products are formulated to fulfill dietary requirements, promoting optimal health and growth in animals.

- Performance Enhancement: Supplements aimed at enhancing production metrics in livestock, such as weight gain, milk production, and overall vitality.

Conclusion

In summary, Zoetis Inc. stands out as a comprehensive provider of animal health solutions, addressing the diverse needs of various species and their caretakers. With an extensive portfolio encompassing pharmaceuticals, vaccines, diagnostics, genetic testing, nutritional supplements, and advanced management solutions, the company demonstrates its commitment to ensuring the well-being of animals and supporting the people responsible for their care. Through continuous innovation and a deep-rooted dedication to animal health, Zoetis is setting the standard for excellence within the industry globally.


Composition of Zoetis Inc Revenues by Segments

 
United States    95.46 % of total Revenue
Australia    7.41 % of total Revenue
Brazil    7.82 % of total Revenue
Canada    5.88 % of total Revenue
Chile    2.92 % of total Revenue
China    5.06 % of total Revenue
France    3.12 % of total Revenue
Germany    5.19 % of total Revenue
Italy    3.2 % of total Revenue
Horses    6.08 % of total Revenue
Mexico    3.85 % of total Revenue
Spain    3.36 % of total Revenue
United Kingdom    6.08 % of total Revenue
Other developed markets    14.42 % of total Revenue
Other emerging markets    22.69 % of total Revenue
Total geographical area    189.55 % of total Revenue
Contract Manufacturing and Human Health Diagnostics    2.11 % of total Revenue
International    94.08 % of total Revenue
Companion Animal    130.75 % of total Revenue
Livestock    58.79 % of total Revenue
Dogs and Cats    124.68 % of total Revenue
Cattle    31.69 % of total Revenue
Swine    9.72 % of total Revenue
Poultry    9.44 % of total Revenue
Fish    6.04 % of total Revenue
Manufactured Product, Other    1.9 % of total Revenue
Parasiticides    52.03 % of total Revenue
Vaccines    42.14 % of total Revenue
Dermatology    30.27 % of total Revenue
Anti-infective Products    19.65 % of total Revenue
Pain & Sedation    17.02 % of total Revenue
Other pharmaceuticals    13.21 % of total Revenue
Animal health diagnostics    9.72 % of total Revenue
Other Non Pharmaceuticals    5.51 % of total Revenue
Total products and services    189.55 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
United States 2,356.00 95.46 %
Australia 183.00 7.41 %
Brazil 193.00 7.82 %
Canada 145.00 5.88 %
Chile 72.00 2.92 %
China 125.00 5.06 %
France 77.00 3.12 %
Germany 128.00 5.19 %
Italy 79.00 3.2 %
Horses 150.00 6.08 %
Mexico 95.00 3.85 %
Spain 83.00 3.36 %
United Kingdom 150.00 6.08 %
Other developed markets 356.00 14.42 %
Other emerging markets 560.00 22.69 %
Total geographical area 4,678.00 189.55 %
Contract Manufacturing and Human Health Diagnostics 52.00 2.11 %
International 2,322.00 94.08 %
Companion Animal 3,227.00 130.75 %
Livestock 1,451.00 58.79 %
Dogs and Cats 3,077.00 124.68 %
Cattle 782.00 31.69 %
Swine 240.00 9.72 %
Poultry 233.00 9.44 %
Fish 149.00 6.04 %
Manufactured Product, Other 47.00 1.9 %
Parasiticides 1,284.00 52.03 %
Vaccines 1,040.00 42.14 %
Dermatology 747.00 30.27 %
Anti-infective Products 485.00 19.65 %
Pain & Sedation 420.00 17.02 %
Other pharmaceuticals 326.00 13.21 %
Animal health diagnostics 240.00 9.72 %
Other Non Pharmaceuticals 136.00 5.51 %
Total products and services 4,678.00 189.55 %
Total 2,468.00 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
United States 73.75 % 116.15 %
Australia 120.48 % 105.62 %
Brazil 107.53 % 114.44 %
Canada 98.63 % 98.63 %
Chile 100 % 89.47 %
China 73.61 % 98.41 %
France 133.33 % 108.11 %
Germany 120.69 % 116.95 %
Italy 107.89 % 102.56 %
Horses 108.33 % 97.37 %
Mexico 150 % 97.92 %
Spain 124.32 % 107.5 %
United Kingdom 94.81 % 92.31 %
Other developed markets 119.75 % 110.65 %
Other emerging markets 148.89 % 92.44 %
Total geographical area 92.83 % 108.93 %
Contract Manufacturing and Human Health Diagnostics - -
International 117.01 % 102.09 %
Companion Animal - -
Livestock 127.43 % 101.53 %
Dogs and Cats 79.31 % 113.24 %
Cattle 144.38 % 99.49 %
Swine 101.68 % 95.12 %
Poultry 126.21 % 97.46 %
Fish 101.35 % 125.76 %
Manufactured Product, Other - -
Parasiticides 90.79 % 119.11 %
Vaccines 106.35 % 100.39 %
Dermatology 61.34 % 114.04 %
Anti-infective Products - -
Pain & Sedation - -
Other pharmaceuticals - -
Animal health diagnostics 118.18 % 105.13 %
Other Non Pharmaceuticals - -
Total products and services 92.83 % 108.93 %
Total 0.33 % 9.11 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total 691.00 28 %




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total -3.76 % 14.98 %




Annual Report on Zoetis Inc Divisions, Sales by Country

 
United States   United States Segment contribution to total sales 53.84 % of total Revenue
Horses   Horses Segment contribution to total sales 66.37 % of total Revenue
Other developed markets   Other developed markets Segment contribution to total sales 6.77 % of total Revenue
Other emerging markets   Other emerging markets Segment contribution to total sales 9.64 % of total Revenue
Contract Manufacturing and Human Health Diagnostics   Contract Manufacturing and Human Health Diagnostics Segment contribution to total sales 1.23 % of total Revenue
Companion Animal   Companion Animal Segment contribution to total sales 69.58 % of total Revenue
Livestock   Livestock Segment contribution to total sales 29.2 % of total Revenue
Dogs and Cats   Dogs and Cats Segment contribution to total sales 3.21 % of total Revenue
Cattle   Cattle Segment contribution to total sales 15.76 % of total Revenue
Swine   Swine Segment contribution to total sales 4.92 % of total Revenue
Poultry   Poultry Segment contribution to total sales 4.56 % of total Revenue
Fish   Fish Segment contribution to total sales 3.02 % of total Revenue
Parasiticides   Parasiticides Segment contribution to total sales 24.73 % of total Revenue
Vaccines   Vaccines Segment contribution to total sales 20.69 % of total Revenue
Dermatology   Dermatology Segment contribution to total sales 18.53 % of total Revenue
Other pharmaceuticals   Other pharmaceuticals Segment contribution to total sales 7.36 % of total Revenue
Animal health diagnostics   Animal health diagnostics Segment contribution to total sales 4.58 % of total Revenue
Anti-infectives   Anti-infectives Segment contribution to total sales 10.94 % of total Revenue
International Euro Member Countries Euro   International Euro Member Countries Euro Segment contribution to total sales 10.54 % of total Revenue
Medicated feed additives   Medicated feed additives Segment contribution to total sales 0.29 % of total Revenue
AUSTRALIA   AUSTRALIA Segment contribution to total sales 3.48 % of total Revenue
BRAZIL   BRAZIL Segment contribution to total sales 4.15 % of total Revenue
CANADA   CANADA Segment contribution to total sales 3.06 % of total Revenue
CHILE   CHILE Segment contribution to total sales 1.47 % of total Revenue
CHINA   CHINA Segment contribution to total sales 2.4 % of total Revenue
FRANCE   FRANCE Segment contribution to total sales 1.74 % of total Revenue
GERMANY   GERMANY Segment contribution to total sales 2.49 % of total Revenue
ITALY   ITALY Segment contribution to total sales 1.45 % of total Revenue
JAPAN   JAPAN Segment contribution to total sales 1.63 % of total Revenue
MEXICO   MEXICO Segment contribution to total sales 1.69 % of total Revenue
SPAIN   SPAIN Segment contribution to total sales 1.53 % of total Revenue
UNITED KINGDOM   UNITED KINGDOM Segment contribution to total sales 3.43 % of total Revenue
Total Geographical Area   Total Geographical Area Segment contribution to total sales 98.77 % of total Revenue
United States Segment   United States Segment Segment contribution to total sales 53.84 % of total Revenue
International Segment   International Segment Segment contribution to total sales 44.94 % of total Revenue
Livestock United States Segment   Livestock United States Segment Segment contribution to total sales 9.26 % of total Revenue
Livestock International Segment   Livestock International Segment Segment contribution to total sales 19.93 % of total Revenue
Companion Animal United States Segment   Companion Animal United States Segment Segment contribution to total sales 44.58 % of total Revenue
Companion Animal International Segment   Companion Animal International Segment Segment contribution to total sales 25 % of total Revenue
Other   Other Segment contribution to total sales 0.93 % of total Revenue
Other non-pharmaceuticals   Other non-pharmaceuticals Segment contribution to total sales 2.78 % of total Revenue
Total Products and Services   Total Products and Services Segment contribution to total sales 98.77 % of total Revenue
Pain Sedation   Pain Sedation Segment contribution to total sales 8.87 % of total Revenue


Twelve months ended 2025
ZTS s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
United States 5,097.00 53.84 %
Horses 6,283.00 66.37 %
Other developed markets 641.00 6.77 %
Other emerging markets 913.00 9.64 %
Contract Manufacturing and Human Health Diagnostics 116.00 1.23 %
Companion Animal 6,587.00 69.58 %
Livestock 2,764.00 29.2 %
Dogs and Cats 304.00 3.21 %
Cattle 1,492.00 15.76 %
Swine 466.00 4.92 %
Poultry 432.00 4.56 %
Fish 286.00 3.02 %
Parasiticides 2,341.00 24.73 %
Vaccines 1,959.00 20.69 %
Dermatology 1,754.00 18.53 %
Other pharmaceuticals 697.00 7.36 %
Animal health diagnostics 434.00 4.58 %
Total 9,467.00 100 %
Anti-infectives 1,036.00 10.94 %
International Euro Member Countries Euro 998.00 10.54 %
Medicated feed additives 27.00 0.29 %
AUSTRALIA 329.00 3.48 %
BRAZIL 393.00 4.15 %
CANADA 290.00 3.06 %
CHILE 139.00 1.47 %
CHINA 227.00 2.4 %
FRANCE 165.00 1.74 %
GERMANY 236.00 2.49 %
ITALY 137.00 1.45 %
JAPAN 154.00 1.63 %
MEXICO 160.00 1.69 %
SPAIN 145.00 1.53 %
UNITED KINGDOM 325.00 3.43 %
Total Geographical Area 9,351.00 98.77 %
United States Segment 5,097.00 53.84 %
International Segment 4,254.00 44.94 %
Livestock United States Segment 877.00 9.26 %
Livestock International Segment 1,887.00 19.93 %
Companion Animal United States Segment 4,220.00 44.58 %
Companion Animal International Segment 2,367.00 25 %
Other 88.00 0.93 %
Other non-pharmaceuticals 263.00 2.78 %
Total Products and Services 9,351.00 98.77 %
Pain Sedation 840.00 8.87 %


Twelve months ended 2025
ZTS s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total 2,673.00 28.23 %
United States Segment 0.00 0 %
International Segment 0.00 0 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
United States 0.45 % -
Horses 4.84 % -
Other developed markets 13.65 % -
Other emerging markets 5.55 % -
Contract Manufacturing and Human Health Diagnostics 45 % -
Companion Animal 4.92 % -
Livestock -4.62 % -
Dogs and Cats 6.67 % -
Cattle -2.55 % -
Swine -9.69 % -
Poultry -18.03 % -
Fish 18.18 % -
Parasiticides 8.73 % -
Vaccines 7.22 % -
Dermatology 5.98 % -
Other pharmaceuticals 5.93 % -
Animal health diagnostics 12.44 % -
Total 2.28 % 7.09 %
Anti-infectives -5.82 % -
International Euro Member Countries Euro 6.51 % -
Medicated feed additives -90.78 % -
AUSTRALIA 3.13 % -
BRAZIL -5.07 % -
CANADA 4.69 % -
CHILE 13.01 % -
CHINA -15.93 % -
FRANCE 5.77 % -
GERMANY 4.89 % -
ITALY 6.2 % -
JAPAN 4.76 % -
MEXICO -5.33 % -
SPAIN 11.54 % -
UNITED KINGDOM 3.5 % -
Total Geographical Area 1.91 % -
United States Segment 0.45 % 2.33 %
International Segment 3.71 % 1.76 %
Livestock United States Segment -14.02 % -
Livestock International Segment 0.48 % -
Companion Animal United States Segment 4.09 % -
Companion Animal International Segment 6.43 % -
Other 7.32 % -
Other non-pharmaceuticals 3.95 % -
Total Products and Services 1.91 % -
Pain Sedation -1.29 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.